RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

Go back to RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

RedHill Biopharma (RDHL) Reports Q4 Operating Loss of $20.7M

March 17, 2022 8:04 AM EDT

RedHill Biopharma (NASDAQ: RDHL) reported Q4 operating loss of $20.7 million. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $24.08 million.

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

... More